Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: Signature construction and molecular subtype identification based on liver-specific genes for prediction of prognosis, immune activity, and anti-cancer drug sensitivity in hepatocellular carcinoma

Fig. 1

LSGs-based HCC subtypes and their differences in clinical characters. A Bases on LSGs expressions, HCCs were separated into three subtypes. B The expression profiles of 20 LSGs in TCGA-HCC. C, D Among the three subtypes, C1 HCCs presented shortest OS and DFS. E, F The unfavorable prognostic effects of C1 subtype on HCC OS and DFS were independent of age, sex, and tumor stage. G, H The comparisons of tumor stage and tumor grade among different HCC subtypes. Cluster analysis, Kaplan-Meier survival analysis with log-rank test, multivariable Cox regression analysis and Chi-square test were performed and p < 0.05 was considered statistically significant

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us